Sperm immobilizing antibodies interfere with sperm migration from the uterine cavity through the fallopian tubes.
OBJECTIVE
It is well known that sperm migration in cervical mucus is impaired by sperm immobilizing antibodies secreted in the mucus. However, it is not clear yet whether sperm migration from the uterine cavity through the fallopian tubes to the peritoneal cavity is impaired by sperm immobilizing antibodies. To test the possible impairment of sperm migration in the tubes, laparoscopic examinations were carried out and the presence of motile sperm in the peritoneal fluid after intra-uterine insemination was investigated.


METHODS
Peritoneal sperm recovery tests were performed in 28 infertile women with sperm immobilizing antibodies in their sera, and the results were compared with those in 322 infertile women without the antibodies. Both the sperm immobilizing antibody titers (SI50) and complement activities (C'H50) in peritoneal fluid were compared with those in patients' sera. In some experiments, the supernatant of the peritoneal fluid was used as a source of complement for the sperm immobilization tests instead of guinea pig serum.


RESULTS
Among couples with normal semen characteristics by the criteria of WHO, sperm recovery in the peritoneal fluid was observed in only 3 (11.1%) of 27 patients with sperm immobilizing antibodies, compared with 72 (34.0%) of 212 patients without the antibodies (P < 0.025). The antibody titers of the patients with the sperm recovery were very low by the quantitative sperm immobilization test. In most patients, a similar amount of sperm immobilizing antibodies was present in the peritoneal fluid and the sera. Though the complement activities in the peritoneal fluid were less than those in sera, the former were still found to be sufficient to immobilize sperm in vivo.


CONCLUSIONS
These results suggest that the complement-dependent sperm immobilizing antibodies could interfere with sperm migration in the female genital tract at the level of the fallopian tubes.
Department of Obstetrics and Gynecology, Hyogo Medical College, Japan.
H
H
Shibahara
M
M
Shigeta
H
H
Toji
K
K
Koyama
D000818:Animals; D001202:Ascitic Fluid / Q000166:cytology / Q000276:immunology; D001323:Autoantibodies / Q000009:adverse effects* / Q000097:blood; D015941:Complement Hemolytic Activity Assay; D005187:Fallopian Tubes / Q000276:immunology*; D005260:Female; D006168:Guinea Pigs; D006801:Humans; D007248:Infertility, Male / Q000276:immunology; D008297:Male; D013081:Sperm Motility / Q000276:immunology*; D013083:Sperm Transport / Q000276:immunology*; D014599:Uterus / Q000276:immunology*
D001323:Autoantibodies